We are live on
!
Find out more
ASA
Armstrong Shaw Associates Portfolio holdings
AUM
$95.2M
1-Year Est. Return
23.67%
This Fund
S&P 500
This Quarter
Est. Return
+10.94%
1 Year Est. Return
+23.67%
3 Year Est. Return
+51.2%
5 Year Est. Return
+82.8%
10 Year Est. Return
+225.63%
AUM
$104M
AUM Growth
+$8.56M
(+8.9%)
Cap. Flow
-$905K
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
47.38%
Holding
41
New
2
Increased
3
Reduced
25
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$2.91M |
| 2 |
CVS Health
CVS
|
+$1.44M |
| 3 |
Halliburton
HAL
|
+$1.35M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$719K |
| 5 |
Zimmer Biomet
ZBH
|
+$222K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$2.66M |
| 2 |
Honeywell
HON
|
+$1.52M |
| 3 |
AGN
Allergan plc
AGN
|
+$1.26M |
| 4 |
State Street
STT
|
+$1.12M |
| 5 |
Microsoft
MSFT
|
+$81.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.52% |
| 2 | Technology | 16.44% |
| 3 | Healthcare | 15% |
| 4 | Energy | 12.62% |
| 5 | Industrials | 8.15% |
Similar funds
AEPLI
GG
VI
TAM
WCM
QT
OC
KC
Armstrong Shaw Associates's Q1 2019 Portfolio in Review
As of Q1 2019, Armstrong Shaw Associates held 41 positions worth $104M, up 8.9% from $95.7M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Armstrong Shaw Associates's Q1 2019 filing shows 2 new, 3 increased, 25 reduced and 2 closed positions. Its largest new stake was Constellation Brands: 17,290 shares worth $3.03M. The largest sale was Elevance Health, an estimated $2.66M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- Armstrong Shaw Associates's largest Q1 2019 buy was Constellation Brands: 17,290 shares worth $3.03M.
- Armstrong Shaw Associates added most to CVS Health in Q1 2019, an estimated $1.44M increase.
- Armstrong Shaw Associates's biggest Q1 2019 reduction was Elevance Health, cutting an estimated $2.66M.
- Armstrong Shaw Associates fully exited Allergan plc in Q1 2019, selling an estimated $1.26M.
- Armstrong Shaw Associates's ten largest holdings make up 47% of its $104M portfolio in Q1 2019.
- Armstrong Shaw Associates opened 2 new positions and closed 2 in Q1 2019.
- Armstrong Shaw Associates's portfolio value rose 8.9% quarter-over-quarter to $104M.
Based on Armstrong Shaw Associates's 13F filing for Q1 2019, filed 8 May 2019.